TWEM aims to explore the future of reproductive health care by speaking with researchers, clinicians, innovators, and advocates to unpack the latest evidence, challenge outdated thinking, and ask one important question: What’s next for women’s health?
We sat down with Dr. Ramakrishnan Kommagani to explore how his research is uncovering the role of the gut microbiome in endometriosis and paving the way for new approaches to diagnosis and treatment.
Dr. Ramakrishnan Kommagani is a professor in the Department of Pathology and Immunology at Baylor College of Medicine in Houston, Texas. Dr. Kommagani seeks to decipher the molecular processes underlying the female reproductive tract functions. His studies involve the role of gut bacteria and inflammation in endometriosis and the role of RNA splicing in gynecological pathologies and embryo implantation.
Why did you decide to study endometriosis in your research? What got you interested in this topic?
The reason why I started studying endometriosis is probably more destiny than anything. I was trained as a molecular biologist with a focus on cancer biology. However, destiny brought me to Baylor College of Medicine to work on reproductive biology in Dr. Bathomali's lab as a postdoc, to study reproductive tissue. When I was trying to start my independent research career, I decided I wanted to work on endometriosis for two fundamental reasons. One, how understudied, underappreciated this disease is. And the disease is not just a simple disease, it's an extremely complex disease. Complex from a clinical suffering perspective, but also complex from a biological perspective, because the disease involves hormonal imbalance, immune dysfunction, inflammation, pain, and it impacts on a daily basis. So that really drew me. I really want to focus on this because it's from a biological perspective extremely complex, challenging.
What are some of the current studies that you are developing with your research group?
We focus on women's health, primarily reproductive health. One is to understand what are the normal processes that allow pregnancy success, and if not, what is the imbalance that impacts fertility status or pregnancy outcomes? We study RNA splicing, which is like molecular scissors. Humans are evolved to use DNA, our genetic code, and then make proteins, which are our functional workforce. But there is a key intermediate in between that called mRNA (messenger RNA) that takes the code from DNA and then transfers so that you get a specific protein from the code. That process is splicing: it removes the unwanted parts and then you have to combine the wanted pieces, and make a workable solution for proteins. We study how that process impacts the uterus to do its job, communicate with the embryo, make sure the uterus expands and support the growth of the embryo. What we also study is how this process is malfunctioned or is not normal in gynecological pathologies such as endometriosis and endometrial cancer. We have shown that this process is important for both. RNA is not made properly, and they lead to the disease progression in endometrial cancer, same with the endometriosis.
Apart from that, we focus on endometriosis and on gut microbiome, the role of our own gut in this particular disease. What we found out is that in mice, the experimental models, or humans, the gut microbiota is changed. If you compare normal with endometriosis, there are changes in bacterial profiles. We found that bacteria, in fact, control the disease progression, and that there are good bacteria, bad bacteria. How do they do it? What bacteria does is use our own energy, our diet, to generate secondary metabolites or compounds that can reach the lesion and do good or bad. So we found some metabolites which actually promote disease, but also some metabolites which actually inhibit the disease progression.
And later, we did the human studies where we collected stool samples from women. We found there are certain signatures of metabolites different from healthy women versus women who are suffering from this disease. Also, we found a couple of metabolites which are not generated by humans, but have to be generated by bacteria. And they are extremely beneficial because when we tested them in human models or the cell lines from patient derived lesions, it completely inhibits the disease progression. So that's a very good therapeutic molecule. But we just have to go beyond just the observational studies.
Do you think that modifying lifestyle factors such as what we eat could actually mediate endometriosis symptoms by changing gut microbiome?
Our research clearly points to what we consume, diet, could impact the disease. So a healthy diet is good. For example, fiber utilization by bacteria leads to generation of small molecules called short-chain fatty acids. When we tested a couple of those, they completely inhibited the disease in experimental mouse cells. A good fiber [filled] diet, good healthy habits, I’m sure, are going to be very helpful.
A recent study from the University of Scotland also showed that consuming a lot of caffeine or complex carbohydrates could actually promote the disease. And our studies also showed that one of the metabolites that is part of caffeine actually promotes the disease. So women who consume more coffee appear to have more endometriosis.
So, yes, diet is very important, healthy habits, any diet that helps to produce more protective metabolites that enrich good bacteria, is going to be helpful for women with endometriosis. But I want to be very honest, I think these are anecdotal, and we really have to do in-depth studies.
Many of our previous guests do clinical studies in human patients. As a basic science researcher, how do studies with animal models or cells help advance our knowledge and help people with endometriosis?
The goal is always to help women with endometriosis. But we cannot simply study that in humans, especially since this is a complex disease. So you cannot take lesions after surgery and use those cells and then try to come up with some therapeutic molecules or try to understand the biology of the disease. Without understanding biology, we cannot design better treatment options. Mouse models are very informative, but they are not the end points. Or the cells or organoids are very informative but not the endpoint.
These animal models, the cell-based models, are tools to understand the biology better and to understand the disease better and hopefully transform that into a clinical setting. The animal models are very important because the disease is not a simple disease. There is a hormonal imbalance. The gut plays a role. The brain plays a role, because women suffer from pain. And we know now a lot of studies showing women who suffer with endometriosis have other comorbidities. Many suffer from digestive conditions. Some women have some increase in blood pressure. So it's holistic.
How can you study that? You cannot simply study it on a cell, because if you take the uterus, there's epithelial cells, stromal cells, and muscle cells. They all communicate. Now we are talking about a complex disease that communicates endometrial cells within a lesion surrounding probably fatty molecules, immune cells, neurons. And these lesions grow very fast so they need a lot of blood vessels. They're so complex. They all have to talk. So that's why animal models are very good to study or understand basic biology. But then the animals do not contain the same genetic architecture.
The cells/organoid models will help us to study the molecular aspects. So these tools allow us to understand the disease biology more and they are absolutely required, but they are not the final.
What are some recent discoveries that have been transformative for endometriosis research, either for developing therapies or discovering the mechanisms behind the disease?
There is no personal bias here, but I definitely think this aspect of microbiome in endometriosis is transformative. We showed that there is a direct link between gut microbiome and endometriosis. Gut microbiome is the link between endometriosis and IBD and IBS. But also we know the gut is like a second small brain. So there is a gut-brain axis, they constantly talk to each other based on our diet. There's probably more than 200 publications showing there is a critical link. We are at the forefront in showing that our microbiome is not an end product that is altered, but is actually causal for the disease. Our focus and that of some other groups who are in Europe is trying to take advantage of this new concept to come up with non-invasive diagnostics. In our case, we are using stools, some [groups] use the vaginal microbiome.
We know it takes up to seven years to diagnose the disease. So imagine women who are in gynecological deserts, rural, remote areas where they probably don't have access to a gynecologist. These kinds of tests, simple at-home tests, will be fantastic.
As a researcher dedicating so much time in understanding the role of the gut microbiome in endometriosis, what is your opinion about the estrobolome?
The estrobolome in relation to the microbiome, I'm sure will have an impact. Estrogen does play a role in this disease. The experimental models show that estrogen is very much required for the initial stages of the disease initiation and the establishment of inflammation. There are certain microbiomes that impact the synthesis of estrogen. So if some women have these bacteria enriched and they are producing more than what they are supposed to be, then of course, adversely impact the disease condition. So in fact, I have a visiting PhD student who is focusing on this aspect. I'm sure some other groups, especially in China, have shown that there is a relation between the estrobolome and endometriosis.
Basic science discoveries often take years to reach patients. How do you see the pathway from findings from your lab to real world treatment for people living with endometriosis?
Given how far we have already gone in terms of establishing that women with endometriosis have different bacterial profiles, how could you take advantage of that? We could detect bacteria in stool samples. That is kind of a reference to the gut bacteria. But also we are interested in metabolites derived from bacteria in stool which we have published recently that could differentiate women with and without endometriosis, and trying to, through a startup biotech company, develop this tool where women can collect the the stool sample at home, ship back to our clinical lab where it will be processed and measured for certain metabolites. We don't want to measure one metabolite, we have found twelve potential metabolites. And then we can send back the results to the physician and that can serve as a non-invasive based diagnostic tool.
Apart from that, diagnostics are ways to detect this disease. Ultimately we have to treat it. So we are also focusing on microbial based therapies. The metabolites we found, we are trying to make better versions of it. Those versions of metabolites should be less toxic, can easily be taken orally so they can be absorbed in our own gut easily to serve the purpose of a better therapeutic. We are also interested in identifying specific bacteria that make these protective metabolites, so we could use it as an engineered bacteria or a probiotic.
I have these two arms within my lab. This is what we are trying to do: develop a non-invasive kit but also focus on therapeutics parallelly, from an academic setting but also potential startups.
What does This Won't End Us mean in your perspective?
It resonates resilience. The resilience of women who are suffering from this particular disease and the quality of life that is impacted. A lot of times they cannot simply say that I have endometriosis, I'm really having some pelvic pain and that I cannot do certain things. Women are so strong in that they endure these pains and the disease that impacts so many parts of their life. So they are resilient in moving on, trying to live through these adversities. This won't end us means it's not gonna stop us to do what we have to do. And you have to keep on moving on.
I get so many emails from women who are suffering from this disease. I'm moved by some of the emails where moms say that their kids were impacted from age twelve, went through four surgeries, still not able to come out of this condition. But you have to understand [that] at age twelve, they have to go to school, play with kids, have fun with their peers, make their own life. So it is important to listen to those voices and This Won't End Us gives a voice for those women and the teens.
Dr. Kommagani is one of many researchers working to advance our understanding of endometriosis and improve the quality of life of those affected by the disease. We are inspired by his dedication to uncovering the complex biological mechanisms underlying endometriosis, particularly the role of the gut microbiome, and his commitment to translating these discoveries into new approaches for non-invasive diagnosis and treatment. We thank Dr. Kommagani for sharing his time and insights with us and applaud his continued contributions to women's health research. For more information on Dr. Kommagani and his research, please visit:
https://www.bcm.edu/research/faculty-labs/ramakrishna-kommagani-lab